Arbutus Biopharma Corp Restructuring Reserve, Period Increase (Decrease)
Arbutus Biopharma Corp (ABUS) reported Restructuring Reserve, Period Increase (Decrease) of $1.33 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodIncreaseDecrease · last filed 2019-03-07
- Arbutus Biopharma Corp restructuring reserve, period increase (decrease) for the quarter ending 2018-12-31 was $561.00K.
- Arbutus Biopharma Corp restructuring reserve, period increase (decrease) for the quarter ending 2018-09-30 was -$320.00K.
- Arbutus Biopharma Corp restructuring reserve, period increase (decrease) for the quarter ending 2018-06-30 was $61.00K.
- Arbutus Biopharma Corp restructuring reserve, period increase (decrease) for the quarter ending 2018-03-31 was $1.03M.
- Arbutus Biopharma Corp restructuring reserve, period increase (decrease) for fiscal 2018 was $1.33M.
| Period end | Restructuring Reserve, Period Increase (Decrease) 3 month | Restructuring Reserve, Period Increase (Decrease) 6 month | Restructuring Reserve, Period Increase (Decrease) 9 month | Restructuring Reserve, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $241.00K derived: sum of 2 quarters · filed 2019-03-07 | $302.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.33M 10-K · filed 2019-03-07 |
| 2018-09-30 | -$320.00K 10-Q · filed 2018-11-07 | -$259.00K derived: sum of 2 quarters · filed 2018-11-07 | $770.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $61.00K 10-Q · filed 2018-11-07 | $1.09M derived: sum of 2 quarters · filed 2018-11-07 | ||
| 2018-03-31 | $1.03M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |